These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27697050)

  • 1. Hybrid Compounds as Multitarget Directed Anticancer Agents.
    Kucuksayan E; Ozben T
    Curr Top Med Chem; 2017; 17(8):907-918. PubMed ID: 27697050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Compounds as Direct Multitarget Ligands: A Review.
    de Oliveira Pedrosa M; Duarte da Cruz RM; de Oliveira Viana J; de Moura RO; Ishiki HM; Barbosa Filho JM; Diniz MF; Scotti MT; Scotti L; Bezerra Mendonca FJ
    Curr Top Med Chem; 2017; 17(9):1044-1079. PubMed ID: 27697048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Targeted Anticancer Agents.
    Zheng W; Zhao Y; Luo Q; Zhang Y; Wu K; Wang F
    Curr Top Med Chem; 2017 Nov; 17(28):3084-3098. PubMed ID: 28685693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances (2015-2016) in anticancer hybrids.
    Kerru N; Singh P; Koorbanally N; Raj R; Kumar V
    Eur J Med Chem; 2017 Dec; 142():179-212. PubMed ID: 28760313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
    Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
    Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues.
    Fedorov SN; Stonik VA; Honecker F; Dyshlovoy SA
    Curr Med Chem; 2017; 24(42):4779-4799. PubMed ID: 27903218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the development of hybrid anticancer drugs.
    Fortin S; Bérubé G
    Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents.
    Peter S; Aderibigbe BA
    Curr Top Med Chem; 2024; 24(7):644-665. PubMed ID: 38357952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Future directions of anticancer drug development in Japan].
    Akaza H; Kawai K; Tsuruo T; Tsukagoshi S; Aiba K; Shimada Y; Kakeji Y; Ishikawa H; Ikeda T; Nakamura S; Tamura T; Yamamoto N; Isonishi S; Hinotsu S; Hirose M; Katsura J
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):351-60. PubMed ID: 18281781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.
    Zhan XP; Lan L; Wang S; Zhao K; Xin YX; Qi Q; Wang YL; Mao ZM
    Chem Biodivers; 2017 Feb; 14(2):. PubMed ID: 27696660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and characterization of novel quinacrine analogs that preferentially kill cancer over non-cancer cells through the down-regulation of Bcl-2 and up-regulation of Bax and Bad.
    Solomon VR; Almnayan D; Lee H
    Eur J Med Chem; 2017 Sep; 137():156-166. PubMed ID: 28586716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrazole Derivatives as Promising Anticancer Agents.
    Popova EA; Protas AV; Trifonov RE
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1856-1868. PubMed ID: 28356016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaloid-metal based anticancer agents.
    Chen ZF; Liu YC; Huang KB; Liang H
    Curr Top Med Chem; 2013; 13(17):2104-15. PubMed ID: 23978139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
    Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
    Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.
    Nepali K; Sharma S; Sharma M; Bedi PM; Dhar KL
    Eur J Med Chem; 2014 Apr; 77():422-87. PubMed ID: 24685980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel phenyl -1, 4-beta-carboline-hybrid molecules as potential anticancer agents.
    Samundeeswari S; Chougala B; Holiyachi M; Shastri L; Kulkarni M; Dodamani S; Jalalpur S; Joshi S; Dixit S; Sunagar V; Hunnur R
    Eur J Med Chem; 2017 Mar; 128():123-139. PubMed ID: 28171832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.
    Dadashpour S; Emami S
    Eur J Med Chem; 2018 Apr; 150():9-29. PubMed ID: 29505935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
    Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
    Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.